Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JOAO L DE QUEVEDO

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1205231008
CMS profile
1286765
Location
HOUSTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$2,214.39

55 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,214.39 55

By paying entity

PY2025 · entire year · sorted by reported total

Page 1 of 2; records 1–50 of 55 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JOAO L DE QUEVEDO

NPI 1205231008 · CMS profile ID 1286765

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry

HOUSTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 2; records 1–50 of 55 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1205231008?year=2025&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JOAO L DE QUEVEDO, NPI 1205231008, CMS profile ID 1286765. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 55 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1205231008?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). JOAO L DE QUEVEDO, NPI 1205231008, CMS profile ID 1286765. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 55 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1205231008?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
JOAO L DE QUEVEDO, NPI 1205231008, CMS profile ID 1286765, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 2; records 1–50 of 55 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1205231008?year=2025&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

55 matching records · $2,214.39 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 55 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 55.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $29.8412/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290299 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $136.5012/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290295 CMS
Neurocrine BioSciences, Inc. $22.2211/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1243016835 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2.0211/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290291 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.1711/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290287 CMS
Neurocrine BioSciences, Inc. $113.7811/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1242966817 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $31.6411/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290283 CMS
Otsuka America Pharmaceutical, Inc. $25.8111/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227316776 CMS
Janssen Scientific Affairs, LLC $135.3511/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174197946 CMS
Neurocrine BioSciences, Inc. $21.0210/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1243021839 CMS
E.R. Squibb & Sons, L.L.C. $27.5310/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184678396 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.1110/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290274 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2.2610/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290277 CMS
LivaNova USA, Inc. $111.7310/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245678747 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.6210/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290270 CMS
Neurocrine BioSciences, Inc. $30.9109/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1242985859 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.0909/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290265 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $34.7508/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290260 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $122.5008/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290257 CMS
Janssen Pharmaceuticals, Inc $35.2308/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174951511 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.3308/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290252 CMS
Otsuka America Pharmaceutical, Inc. $22.3108/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227316774 CMS
Abbott Laboratories $89.9008/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240722807 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.1407/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290247 CMS
Axsome Therapeutics, Inc. $54.1207/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235422180 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1.6707/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290237 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.5407/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290242 CMS
Takeda Pharmaceuticals U.S.A., Inc. $33.0907/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223930716 CMS
Janssen Pharmaceuticals, Inc $26.8806/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174952542 CMS
Otsuka America Pharmaceutical, Inc. $18.3706/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227316772 CMS
LivaNova USA, Inc. $71.7405/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245678557 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $27.4505/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290233 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.7105/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223838245 CMS
LivaNova USA, Inc. $8.2005/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245678554 CMS
Lundbeck LLC $25.3405/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251788635 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.1605/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290229 CMS
Teva Pharmaceuticals USA, Inc. $27.7904/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247515320 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $32.7204/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290225 CMS
Neurocrine BioSciences, Inc. $29.3004/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1242989621 CMS
ABBVIE INC. $18.2604/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201739972 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $29.1803/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290222 CMS
LivaNova USA, Inc. $66.8903/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245678495 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.3803/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290215 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2.1903/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290218 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $125.0003/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290210 CMS
Lundbeck LLC $21.6703/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251788633 CMS
E.R. Squibb & Sons, L.L.C. $18.0202/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184678348 CMS
Janssen Pharmaceuticals, Inc $129.3802/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174956401 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $29.8202/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241290207 CMS
Neurocrine BioSciences, Inc. $122.0602/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1242965657 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $14,533.11 45
PY2020 $10,739.65 15
PY2021 $2,950.79 10
PY2022 $5,177.81 13
PY2023 $30,607.97 81
PY2024 $2,867.32 56
PY2025 $2,214.39 55

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $198,539.00 282
PY2024 Principal investigator $93,685.00 73
PY2023 Principal investigator $269,170.50 100
PY2022 Principal investigator $195,711.52 29
PY2021 Principal investigator $63,472.50 14

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

73 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $45,796.00 12/16/2024 Non-covered Recipient Entity
THE UNIVERSITY OF TEXAS HEALTH SCIE NCE CENTER AT HOUSTON
A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with Moderate-to-severe Anhedonia an No dispute reported 06/30/2026 1079012236
Principal investigator 1 LivaNova USA, Inc. $170.00 12/05/2024 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1139458161
Principal investigator 1 LivaNova USA, Inc. $256.75 11/30/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456548
Principal investigator 1 LivaNova USA, Inc. $256.75 11/30/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456600
Principal investigator 1 LivaNova USA, Inc. $330.00 11/19/2024 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
The RECOVER sUb-study, which leverages quaNtitative and Credible research tOols from Verily, will providE assessment measuRes for depressive episodes (UNCOVER) No dispute reported 06/30/2026 1139458083
Principal investigator 1 LivaNova USA, Inc. $85.00 11/19/2024 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1139458253
Principal investigator 1 LivaNova USA, Inc. $256.75 10/30/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456546
Principal investigator 1 LivaNova USA, Inc. $256.75 10/30/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456602
Principal investigator 1 LivaNova USA, Inc. $256.75 10/30/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456604
Principal investigator 1 LivaNova USA, Inc. $256.75 10/30/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456606
Principal investigator 1 LivaNova USA, Inc. $256.75 10/30/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456608
Principal investigator 1 LivaNova USA, Inc. $85.00 10/22/2024 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1139458325
Principal investigator 1 LivaNova USA, Inc. $1,280.00 10/03/2024 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
The RECOVER sUb-study, which leverages quaNtitative and Credible research tOols from Verily, will providE assessment measuRes for depressive episodes (UNCOVER) No dispute reported 06/30/2026 1139458121
Principal investigator 1 LivaNova USA, Inc. $85.00 10/03/2024 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1139458419
Principal investigator 1 LivaNova USA, Inc. $256.75 09/20/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456542
Principal investigator 1 LivaNova USA, Inc. $18,143.00 09/20/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456544
Principal investigator 1 LivaNova USA, Inc. $256.75 09/20/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456610
Principal investigator 1 LivaNova USA, Inc. $256.75 09/20/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456612
Principal investigator 1 LivaNova USA, Inc. $256.75 09/20/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456614
Principal investigator 1 LivaNova USA, Inc. $256.75 08/09/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456540
Principal investigator 1 LivaNova USA, Inc. $256.75 08/09/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456616
Principal investigator 1 LivaNova USA, Inc. $256.75 08/09/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456618
Principal investigator 1 LivaNova USA, Inc. $256.75 08/09/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456620
Principal investigator 1 LivaNova USA, Inc. $256.75 08/09/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456622
Principal investigator 1 LivaNova USA, Inc. $256.75 08/09/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456624
Principal investigator 1 LivaNova USA, Inc. $256.75 08/03/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456530
Principal investigator 1 LivaNova USA, Inc. $256.75 08/03/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456658
Principal investigator 1 LivaNova USA, Inc. $256.75 08/03/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456660
Principal investigator 1 LivaNova USA, Inc. $1,280.00 07/30/2024 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1139458583
Principal investigator 1 LivaNova USA, Inc. $820.00 07/23/2024 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1139458609
Principal investigator 1 LivaNova USA, Inc. $1,320.00 07/16/2024 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1139458018
Principal investigator 1 LivaNova USA, Inc. $256.75 07/12/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456538
Principal investigator 1 LivaNova USA, Inc. $256.75 07/12/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456626
Principal investigator 1 LivaNova USA, Inc. $256.75 07/12/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456628
Principal investigator 1 LivaNova USA, Inc. $256.75 07/12/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456630
Principal investigator 1 LivaNova USA, Inc. $256.75 06/07/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456536
Principal investigator 1 LivaNova USA, Inc. $256.75 06/07/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456632
Principal investigator 1 LivaNova USA, Inc. $256.75 06/07/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456634
Principal investigator 1 LivaNova USA, Inc. $256.75 06/07/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456636
Principal investigator 1 LivaNova USA, Inc. $256.75 06/07/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456638
Principal investigator 1 LivaNova USA, Inc. $256.75 06/07/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456640
Principal investigator 1 LivaNova USA, Inc. $256.75 06/07/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456642
Principal investigator 1 LivaNova USA, Inc. $256.75 06/07/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456644
Principal investigator 1 LivaNova USA, Inc. $256.75 06/07/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456646
Principal investigator 1 LivaNova USA, Inc. $256.75 06/07/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456648
Principal investigator 1 LivaNova USA, Inc. $256.75 05/08/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456534
Principal investigator 1 LivaNova USA, Inc. $256.75 05/08/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456650
Principal investigator 1 LivaNova USA, Inc. $256.75 04/19/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456532
Principal investigator 1 LivaNova USA, Inc. $256.75 04/19/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456652
Principal investigator 1 LivaNova USA, Inc. $256.75 04/19/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456654
Principal investigator 1 LivaNova USA, Inc. $256.75 04/19/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456656
Principal investigator 1 LivaNova USA, Inc. $3,990.00 03/12/2024 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1139457626
Principal investigator 1 LivaNova USA, Inc. $3,990.00 03/12/2024 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1139457978
Principal investigator 1 LivaNova USA, Inc. $85.00 02/20/2024 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1139457818
Principal investigator 1 LivaNova USA, Inc. $85.00 02/20/2024 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1139458843
Principal investigator 1 LivaNova USA, Inc. $256.75 02/16/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456528
Principal investigator 1 LivaNova USA, Inc. $256.75 02/16/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456662
Principal investigator 1 LivaNova USA, Inc. $256.75 02/16/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456664
Principal investigator 1 LivaNova USA, Inc. $256.75 02/16/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456666
Principal investigator 1 LivaNova USA, Inc. $256.75 02/16/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456668
Principal investigator 1 LivaNova USA, Inc. $256.75 02/16/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456670
Principal investigator 1 LivaNova USA, Inc. $256.75 02/16/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456672
Principal investigator 1 LivaNova USA, Inc. $1,506.25 01/31/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456550
Principal investigator 1 LivaNova USA, Inc. $256.75 01/12/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456526
Principal investigator 1 LivaNova USA, Inc. $256.75 01/12/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456674
Principal investigator 1 LivaNova USA, Inc. $256.75 01/12/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456676
Principal investigator 1 LivaNova USA, Inc. $256.75 01/12/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456678
Principal investigator 1 LivaNova USA, Inc. $256.75 01/12/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456680
Principal investigator 1 LivaNova USA, Inc. $256.75 01/12/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456682
Principal investigator 1 LivaNova USA, Inc. $256.75 01/12/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456684
Principal investigator 1 LivaNova USA, Inc. $256.75 01/12/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456686
Principal investigator 1 LivaNova USA, Inc. $256.75 01/12/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456688
Principal investigator 1 LivaNova USA, Inc. $256.75 01/12/2024 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
LivaNova UNCOVER No dispute reported 06/30/2026 1139456690